Parexel has confirmed that Panthera Biopartners has become the first UK public or commercial clinical trial organisation to become part of the Parexel Site Alliance Vaccine Network. Parexel’s Site Alliance Vaccine Network is a global network of high performing clinical trial sites which fosters long-term collaborative relationships with select research organizations across the globe to …
Since announcing that it reopened its oncology clinical trials division earlier this year, Panthera Biopartners has been selected by two of the world’s largest pharma companies to run oncology trials at sites across the UK. Panthera previously had to close its Oncology division as the sites were located inside the four Rutherford Specialist Cancer clinics, …
Panthera’s SMO model delivers market-leading patient recruitment for vaccine trials In the post-COVID-19 period, the UK has emerged as a world leader in vaccine trials, but data from two case studies shows that Panthera is not only outperforming global sites, but also competitor sites across the UK. In a recent COVID-19 booster healthy volunteer vaccine trial, Panthera’s …
The UK’s largest Site Management Organisation (SMO), Panthera Biopartners, has opened the first dedicated clinical research site in York. The site, which has been operating since May, was officially opened by the Lord Mayor of York, Councillor Margaret Wells, at an opening ceremony on 25th July 2024. The clinic is located in the Acomb Garth …
Click here to read more: https://lnkd.in/erHjBc6k Includes:* Panthera remains top recruiter of patients in the UK* Panthera delivers outstanding patient recruitment for cardiovascular trials* Panthera launches new clinical research clinic in York* International Clinical Trials interview – Private vs public vaccine studies, how SMOs can secure the future of UK clinical trials* Martyn Jellett appointed as …
Independent clinical trial SMO (Site Management Organisation) Panthera Biopartners has appointed Martyn Jellett as Associate Director Business Development to support its expanding commercial team as the company continues to prosper and expand. Martyn has over 25 years experience in professional sales and business development and has extensive knowledge of the pharmaceutical and medical industry. Panthera, …
International Clinical Trials (ICT): Panthera interview – Private vs public vaccine studies, how SMOs can secure the future of UK clinical trials Panthera’s Ian Smith and Chris Dodd recently spoke to ICT about the differences in private versus public clinical trials, how speed is key in preclinical processes and how the UK can improve its …
Panthera Biopartners has become a world leader in running international vaccine studies. In the last 18 months, Panthera has run eight vaccine studies at its network of clinical trial sites across the UK on behalf of the pharma industry. Panthera’s sites are regularly first in the world or first in the UK in treating the …
Preston-based Panthera Biopartners has been named Pharma Research Centre of the Year at the Pharma Industry Awards UK 2023. The award was given in recognition of the company’s innovative SMO (Site Management Organisation) model, which focuses on speed of start-up, access to more than a million patients – many prequalified – and digitisation of contact and qualification of patients …
Our dedicated patient engagement team, comprising Chris Dodd, Erik Farish, and Sairah Yassir-Deane, had an enriching experience at the ‘Management in Practice’ event in Manchester. We had the opportunity to interact with numerous General Practitioners (GPs) from across the UK, who are keen to introduce the concept of patient engagement in clinical research to their …
